Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 130 | 160 | 60 | 60 | 90 |
| TOTAL | $130 | $160 | $60 | $60 | $90 |
| Non-Current Assets | |||||
| PPE Net | 370 | 350 | 260 | 280 | 290 |
| Other Non-Current Assets | 30 | 40 | 0 | 0 | 0 |
| TOTAL | $400 | $390 | $260 | $280 | $290 |
| Total Assets | $530 | $550 | $320 | $340 | $380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 160 | 560 | 410 | 250 | 700 |
| Accrued Expenses | 2,590 | 2,110 | 2,420 | 2,490 | 2,530 |
| TOTAL | $2,750 | $2,670 | $2,830 | $2,740 | $3,230 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,750 | $2,670 | $2,830 | $2,740 | $3,230 |
| Shareholders' Equity | |||||
| Common Shares | 80 | 60 | 60 | 60 | 60 |
| Other shareholders' equity | -4 | -5 | -4 | -1 | 0 |
| TOTAL | $56,826 | $43,795 | $43,646 | $40,359 | $40,330 |
| Total Liabilities And Equity | $59,576 | $46,465 | $46,476 | $43,099 | $43,560 |